Dr. B. Robert Mozayeni was trained in Internal Medicine and Rheumatology at Yale and at NIH. He has had pre- and post-doctoral Fellowships in Molecular Biophysics and Biochemistry at Yale, and also at NIH where he was a Howard Hughes Research Scholar at LMB/DCBD/NCI and later, Senior Staff Fellow at LMMB/NHLBI/NIH. He is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently. He is a Fellow of the non-profit Think Lead Innovate Foundation and is a co-founder of the Foundation for the Study of Inflammatory Diseases. He is a Founder of the Foundation for the Study of Inflammatory Diseases to crowd-source medical solutions for complex conditions using existing knowledge, diagnostic methods, and therapies to meet patient needs immediately. He is the Chief Medical Officer of Galaxy Diagnostics, LLC. And, he was recently appointed to be a Board member of the Human-Kind Alliance. Dr. Mozayeni has held admitting privileges (since 1994) on the clinical staff of Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the National Institutes of Health Clinical Center.

Dr. Robert C. Bransfield, MD, DLFAPA is a graduate of Rutgers College and the George Washington University School of Medicine. He trained at Sheppard and Enoch Pratt Hospital, is board certified by the American Board of Psychiatry and Neurology in Psychiatry and is a Distinguished Life Fellow of the American Psychiatric Association (APA). Dr. Bransfield’s primary activity is an office based private practice of psychiatry. Dr Bransfield is the Past President of ILADS, the International Lyme and Associated Diseases Educational Foundation and the New Jersey Psychiatric Association. He has held a number of administrative positions with hospitals and organizations involved with health, mental health and community related activities and has received multiple awards from the APA and ILADS, including the Pioneer Award. He is a Clinical Associate Professor of Psychiatry at Rutgers—RWJ Medical School and the Hackensack Meridian School of Medicine. Dr. Bransfield’s clinical activities has focused upon treating patients who are considered to be treatment resistant. Many of these patients were found to have infectious disease contributors to their psychiatric symptoms. As a result, his research has often focused upon the association between infectious disease and mental illness. Dr. Bransfield has authored and co-authored a number of publications in peer-reviewed and other literature and has been active in political advocacy on an international, national, state and local level.

Dr. Rosalie Greenberg is a Board-Certified Adult, Child and Adolescent Psychiatrist, known for her expertise in the diagnosis and management of complex psychiatric problems in children, and pediatric psychopharmacology. Dr. Greenberg received her MD from Columbia University-College of Physicians and Surgeons, where she also completed her training in adult psychiatry, as well as a fellowship in child psychiatry, serving as chief resident. She subsequently served for years on the teaching faculty at Columbia. A firm believer in the power of education, Dr. Greenberg is an author, researcher, lecturer, co-producer of an educational film, and creator and host of an award winning cable TV show, all related to children's health. These various activities have been geared to both medical professionals and the lay public, including presentations at both national and international conferences. Dr. Greenberg brings her 40 years of experience to topics that range from adolescent suicide and pediatric bipolar disorder as well as the many psychological aspects attributed to Lyme disease. Working in New Jersey, where Lyme disease is endemic, she found a sizable number of the children she evaluated, tested positive for tick-borne illness, most of whom never had a known tick bite. For the past few years, she has focused on the psychiatric manifestations of infectious diseases, especially, tick-borne illnesses in children and adolescents.

Prof Lambert is an adjunct Full Clinical Professor and Consultant in Infectious Diseases and Genitourinary Medicine at Mater Misericordiae University Hospital, and Associate Professor at UCD School of Medicine. Current research focused on infections in pregnancy and treatment of HIV and Hepatitis C. Prof Lambert has successfully developed a database at the Rotunda and Mater Hospitals to monitor pregnant women with various infectious diseases, and also monitoring HIV drug levels in HIV positive pregnant women in receipt of HIV therapy. Active in Hepatitis C treatment and also developing national policies and strategies Prof Lambert is the recipient of a 228K two year grant from VIIV Access and Government Affairs department, to develop a paediatric AIDS database in two clinics in Eastern Cape South Africa. This database captures information on 2500 children, approximately 2000 of whom are on HIV treatment and captures important safety and clinical data on these children. Currently Prof Lambert has received further funding of 200K to develop this database in 4 countries: South Africa, Kenya, Swaziland and Zambia. Prof Lambert's is currently developing research into international adolescent HIV. He is leading a multi country study including sites in Dublin, London, Bucharest Romania, Chiang Rai Thailand, Rio de Janeiro Brazil, Mona Jamaica, East London and Durban South Africa, He has been awarded a 237K grant from VIIV Access and Government Affairs for this project. His most recent grant for £150K focusses on Prevention of Mother to Child Transmission of HIV in South Africa. Prof Lambert has also been awarded a 1.8 million euro three year grant to develop a community based intervention for HCV with the Horizons 2020 programme, with location in Dublin, London, Bucharest and Seville.

Dr Carsten Nicolaus is a world-renowned Lyme expert, dedicated to researching, diagnosing, and treating Lyme and other tick-borne diseases. Since 1990, he has advised over 25,000 Lyme patients from more than 80 countries and has trained and mentored over 1,500 doctors since 2006. After obtaining his medical license in 1988 and specializing in organ transplants, he went on to do his doctorate in immunology in Munich. In 1990, having set up his own GP practice in Augsburg, Germany, which he wasn’t aware was in a Lyme endemic area, he began to diagnose and treat patients, realizing that many of the patients he was seeing were suffering from chronic Lyme. Dr Nicolaus immediately pursued specialist training and research into tick-borne diseases so that he was able to better diagnose and treat these patients. Over the past three decades Dr Nicolaus has developed a unique set of protocols and treatment approaches that cutting edge doctors and clinics have successfully adopted in their own practices. Dr Nicolaus founded BCA-clinic in 2006, which was the first and largest Lyme clinic of its kind in Europe. His targeted approach to treatment is the result of years of work conducted in frontline Lyme clinical care, a pioneering research department, and a field-based training academy which all worked together seamlessly under the ownership and steerage of Dr Nicolaus. Over the years the BCA-clinic, BCA-lab and Training Centre gained worldwide recognition and praise as a beacon of hope and treatment success for patients and doctors until its closure in 2020 during the Covid- 19 pandemic.In 2016, Dr Nicolaus co-founded Infectolab Americas (USA) with the aim of developing the highest quality diagnostic testing for viruses and bacteria including Lyme, and other tick-borne diseases. Infectolab Americas (USA) is an independent laboratory that consults with doctors and practitioners regularly who they support with diagnostic interpretation and guidance on treatment. In 2021, Infectolab Americas set up a specialized research department in-house that plays a crucial role in development of ongoing scientific refinements and advancements to the diagnostics they offer. Dr Nicolaus has been an active member of ILADS (International Lyme & Associated Diseases Society) since 2007 having been a board director of the organization as well as treasurer of the educational foundation of ILADS at various junctures in his membership with the group. He is also a long-standing member of ILADEF (International Lyme and Associated Diseases Education Foundation) as well as a member of the medical advisory panel of the Charles E Holman Morgellons Disease Foundation. His work now encompasses not only tick borne/vector-borne diseases but also the associated health conditions that often develop as a result of chronic infections.Dr Nicolaus currently divides his time between the United Kingdom, Germany and North America, speaking at conferences and training medical practitioners in diagnostics and treatment protocols. This, combined with his own ongoing research, aims to further our global understanding in the management and treatment of patients with tick-borne diseases. He continues to provide mentorship and training to doctors and clinics worldwide offering personalized support to doctors who manage patients with complex medical histories. Whilst much progress has been made in understanding and accepting the impact that tick-borne diseases have on people around the world, much remains to be done to create a greater understanding of the tick-borne diseases and their impact on patients. He firmly believes there is a need for a global ‘gold standard’ in diagnostics and treatment protocols that would enable doctors and patients to work together towards a positive health outcome.

Experienced scientist with notable work practice in academic, biotech, private labs and big pharma settings. Addicted to research and strong commitment to develop new diagnostic tools for tick-borne diseases and autism-spectrum disorders. I am also heavily contributing to the discovery and testing of new therapeutic solutions through transfer of knowledge, coordination & management

Hi! I am Dr. Leona Gilbert, co-founder and CEO of Te?ted Oy (Tezted). I have co-founded Tezted with Kunal Garg (Chief Technology Officer) in 2016 as a university spinoff company. Our goal was to help patients with complex diseases (e.g., Lyme disease) to get tested reliably, so they could get timely treatment and recover quicker. I was born in Canada and moved to Finland for love. I am a Docent of Cell and Molecular Biology and I have over 20 years of experience in research-driven initiatives that provided valuable tools for patients. I have a doctorate in biotechnology and a very long experience in bio-innovation and bio-business and have supervised numerous PhD, MSc and BSc students. My various peer-reviewed articles span turning research results into a translational value with developing novel delivery vectors as well as diagnostic lab-on-chip platforms. My publications show the thorough investigation of how a common virus or bacterium can contribute to autoimmune diseases, and demonstrate a multi-disciplinary background and collaborative efforts between clinicians, microbiologists, diagnostic developers, nano-scientists, physicists and engineers, and especially patients. I strive so that my research initiatives into complete diagnostic platforms and clinical profiling of patients for tick-borne and autoimmune diseases will lead to a better understanding of how chronic conditions could be established with infectious pathogens.